Bausch Health Companies Inc. 8-K

What Happened

• Bausch Health Companies Inc. announced that Michael Goettler notified the company on June 26, 2026 that he will resign from the Board of Directors effective June 30, 2026. He is leaving the board in connection with his appointment as President and Chief Executive Officer of Knoa Pharma LLC. The company stated the resignation was not due to any disagreement with Bausch Health’s operations, policies or practices. The notice and related press release were furnished in an 8-K filed July 1, 2026.

Key Details

• Mr. Goettler notified the company on June 26, 2026; resignation effective June 30, 2026.
• Reason given: appointment as President & CEO of Knoa Pharma LLC.
• The company said the resignation was not the result of any disagreement with Bausch Health.
• The resignation and press release were furnished as Exhibit 99.1 to the Form 8-K filed July 1, 2026 (Items 5.02 and 7.01).

Why It Matters

• For investors, this is a board composition change: one director seat will be vacant unless the company names a replacement. The filing contains no indication of related compensation changes or any dispute with management, so the item appears to be a routine director departure for a new executive role elsewhere. Monitor future filings for any announced board replacement or governance updates.